Here's the live share price of Genomic Valley Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Genomic Valley Biotech has gained 10.86% CAGR. Over the past year, the corresponding return has been -69.76%.
Genomic Valley Biotech’s current P/E of 95.26x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Agriculture/Horticulture/Livestock Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech | 2.47 | -1.98 | -28.59 | -47.43 | -69.76 | 0.32 | 10.86 |
| Tierra Agrotech | 3.35 | 26.97 | 8.45 | 14.93 | -25.10 | -29.27 | -28.52 |
| Nath Bio-Genes (India) | -3.16 | -1.95 | -3.36 | 4.66 | -10.78 | -0.37 | -8.78 |
| Genesis IBRC India | 10.35 | 108.25 | 451.57 | 797.08 | 989.54 | 156.85 | 89.29 |
| Mangalam Seeds | -2.50 | -9.39 | -13.61 | -8.13 | -32.29 | 20.39 | 17.95 |
| Vivo Bio Tech | -0.18 | -11.66 | -8.62 | -6.38 | -14.02 | -3.25 | -4.49 |
| Shree Ganesh Bio-Tech (India) | -2.70 | -4.00 | -7.69 | -17.24 | -32.08 | -30.23 | -33.15 |
| Omega Ag-Seeds (Punjab) | 1.40 | -1.22 | 8.24 | 74.03 | -41.26 | 23.51 | 13.51 |
Over the last one year, Genomic Valley Biotech has declined 69.76% compared to peers like Tierra Agrotech (-25.10%), Nath Bio-Genes (India) (-10.78%), Genesis IBRC India (989.54%). From a 5 year perspective, Genomic Valley Biotech has outperformed peers relative to Tierra Agrotech (-28.52%) and Nath Bio-Genes (India) (-8.78%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 30.34 | 31.38 |
| 10 | 30.32 | 31.21 |
| 20 | 31.13 | 31.69 |
| 50 | 36.19 | 35.12 |
| 100 | 42.11 | 40.57 |
| 200 | 50.42 | 47.51 |
In the latest quarter, Genomic Valley Biotech remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 53.29% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 15, 2025, 9:05 PM IST | Genomic Valley Biote - Un-Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th, 2025 |
| Oct 15, 2025, 8:57 PM IST | Genomic Valley Biote - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of Sebi (LODR)Regulation |
| Oct 10, 2025, 5:25 PM IST | Genomic Valley Biote - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 07, 2025, 11:39 PM IST | Genomic Valley Biote - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligati |
| Sep 04, 2025, 10:49 PM IST | Genomic Valley Biote - Intimation Of Approval Of Extension Of Time For Holding Annual General Meeting (AGM) Of The Company Fo |
Genomic Valley Biotech Ltd. is a Public Limited Listed company incorporated on 15/03/1996 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L01122HR1994PLC033029 and registration number is 033029. Currently Company is involved in the business activities of Growing of cucumbers, gherkins, aubergines, tomatoes, watermelons, cantaloupes , melons and other fruit-bearing vegetables. Company's Total Operating Revenue is Rs. 0.84 Cr. and Equity Capital is Rs. 3.05 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Genomic Valley Biotech is ₹31.15 as on Nov 10, 2025.
The Genomic Valley Biotech is operating in the Agriculture / Horticulture / Lives Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Genomic Valley Biotech is ₹9.51 Cr as on Nov 10, 2025.
Today’s highest and lowest price of Genomic Valley Biotech are ₹31.47 and ₹30.02.
The 52-week high/low is the highest and lowest price at which Genomic Valley Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Genomic Valley Biotech is ₹108.15 and 52-week low of Genomic Valley Biotech is ₹27.15 as on Nov 10, 2025.
The Genomic Valley Biotech has shown returns of 0.91% over the past day, -1.98% for the past month, -28.59% over 3 months, -69.76% over 1 year, 0.32% across 3 years, and 10.86% over 5 years.
P/E ratio of and PB ratio of Genomic Valley Biotech are 95.26 and 2.44 on Nov 10, 2025. While the company gives a dividend yield of 0.00 per annum.